Medical News

RSS

Embera NeuroTherapeutics establishes clinical development partnership for its cocaine dependence program

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for drug dependence, smoking cessation and obesity, announced today that the company has retained Exponential Pharma Ventures LLC to assist in establishing a clinical development partnership for its cocaine dependence program with a fully integrated pharmaceutical company.

17 Feb 2010

TopoTarget pays Celldex Therapeutics $3M sublicense income over Belinostat co-development agreement

Celldex Therapeutics, Inc. today announced that it has received a sublicense income payment of $3 million from TopoTarget A/S as a result of the recent co-development and commercialization agreement between TopoTarget and Spectrum Pharmaceuticals, Inc. for Belinostat, a novel histone deacetylase (HDAC) inhibitor for the treatment of cancer.

17 Feb 2010

Infants born to bilingual mothers exhibit different language preferences

It may not be obvious, but hearing two languages regularly during pregnancy puts infants on the road to bilingualism by birth. According to new findings in Psychological Science, a journal of the Association for Psychological Science, infants born to bilingual mothers (who spoke both languages regularly during pregnancy) exhibit different language preferences than infants born to mothers speaking only one language.

17 Feb 2010

Diagenode launches SX-8G IP-Star system for epigenetics

Diagenode, an innovative leader providing products and technologies for epigenetics, genomics and diagnostics, and the only provider of complete epigenetics solutions, announced today the launch of its innovative platform for automated epigenetics assays, the SX-8G IP-Star™ system ("IP-Star™).

16 Feb 2010

American Heart Association announces strategic goal to reduce stroke and cardiovascular diseases

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

16 Feb 2010

Health reform pressure points: Excise tax, individual mandate, antitrust legislation

"An agreement to tax high-cost, employer-sponsored health insurance plans, announced with fanfare by the White House and labor unions last month, is losing support from labor leaders, who say the proposal is too high a price to pay for the limited health care package they expect to emerge from Congress," The New York Times reports.

16 Feb 2010

Chemists adopt new approach to optimise enzyme for practical applications

Engineers are unlikely to tinker with the cooling system if they want to increase the size of an engine. Yet chemists at the Max Planck Institute for Coal Research have adopted an approach similar to this in their efforts to optimise an enzyme for practical applications. They

16 Feb 2010

FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date

CombinatoRx, Incorporated today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for review of the Exalgo™ (hydromorphone HCl) extended-release tablets New Drug Application (NDA) from Monday, February 22, 2010 to Monday, March 1, 2010 due to federal government closings.

16 Feb 2010

New hands-free texting application can prevent vehicular accidents

Gilbert's team developed an application, called VoiceTEXT, that allows drivers to speak text messages and keep their eyes on the road at the same time. Drivers using VoiceTEXT put their cell phones in Bluetooth mode and connect it to their car.

16 Feb 2010

Cancer Research UK, immatics Biotechnologies sign collaboration agreement to trial IMA950 vaccine for GMB

CANCER RESEARCH UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached a collaboration agreement with immatics Biotechnologies to trial their new treatment vaccine, IMA950, for glioblastoma multiforme (GMB), one of the most common forms of brain cancer.

16 Feb 2010

Obama administration announces $1 billion in new health IT grants

HHS Secretary Kathleen Sebelius and Secretary of Labor Hilda Solis Friday announced the release of $1 billion in stimulus funds to expand the use of electronic records and to train health care workers.

16 Feb 2010

Solos Endoscopy announces new polymer dilator for MammoView Breast Endoscopy System

Solos Endoscopy, Inc. is pleased to announce the Company has designed and is set to develop a new polymer dilator for the MammoView™ Breast Endoscopy System. The MammoView™ System currently offers a dilator set with a metal housing. The newly redesigned dilator utilizes a polymer housing, which is significantly softer while still offering comparable durability to the metal dilator. The new polymer dilator will be offered in addition to the more commonly used metal dilator. The two versions of the dilator offer physicians options based on individual patient's requirements.

16 Feb 2010

Researchers use model organism to test new therapies for retinal degeneration

Research by Johns Hopkins sensory biologists studying fruit flies, has revealed a critical step in fly vision. Humans with problems in this same step suffer retinal dystrophies, which manifest as visual defects ranging from mild visual impairments to complete blindness.

16 Feb 2010

Budget cuts hit health care services in Minnesota, Oklahoma and California

Gov. Tim Pawlenty's proposal to cut a net of $347 million from programs for sick, aged, disabled and jobless people is akin to the advice an ailing George Washington got from his doctors 210 years ago, one critic said Monday: Bleed him, in hope of a cure. Pawlenty would eliminate the General Assistance program in which about 20,000 disabled and very-low-income people receive an average of $175 a month.

16 Feb 2010

Biota Holdings reports total revenue of $61.7M for half-year of 2009

Biota Holdings Limited today announced a half year net profit after tax of $33.5 million, (1H F09: $7.2m). Profit before tax was $41.4 million (1H F09: $10.1m) benefiting significantly from an increase in Relenza royalties.

16 Feb 2010

Eat 'heart-healthy' oats to prevent atherosclerosis

Nutritionist Mohsen Meydani, director of the Vascular Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston, Mass., led the research on the oat compounds, called avenanthramides. Meydani previously has shown that phenolic antioxidants in oats obstruct the ability of blood cells to stick to artery walls.

16 Feb 2010

IRS helping thousands pay for health insurance

The IRS is helping more than 40,000 residents of Michigan buy health insurance "after they lost their jobs to foreign competition or had their pension plans terminated," The Detroit News reports.

16 Feb 2010

Teva Novopharm announces name change to Teva Canada Limited

Teva Novopharm announced today it is implementing a name change to Teva Canada Limited, which reinforces the company's relationship with its parent, Teva Pharmaceutical Industries Ltd., the world's largest generic pharmaceutical manufacturer.

16 Feb 2010

Healthcare Trust of America completes 13 acquisitions

Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced that in 2009, HTA completed 13 acquisitions comprised of 54 medical office buildings totaling 2,257,634 square feet and one real estate-related asset. The total purchase price of these acquisitions was approximately $494,259,000.

16 Feb 2010

Positive topline data from Alkermes' phase 1 clinical study of ALKS 37 announced

Alkermes, Inc. today announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC).

16 Feb 2010